Cat.#: ASSD-127
Description | Fluorescent H3 histamine receptor antagonist (apparent KD values are 7.09, 6.55 and 5.71 for H3, H1 and H2 receptors respectively). Also antagonizes the activity of Histamine, a H1 agonist. Displays no intrinsic activity. |
Size | 50 μg |
Applications | For imaging at H3, H2 and H1 receptors use solutions up to 100 nM. |
Molecule Weight | 848.5 |
Purity | >95% |
Solubility | Soluble in DMSO |
Excitation | 633 nm |
Emission | 650 nm |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light and briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
ASSD-211 | 5(6)-Carboxyfluorescein N-hydroxysuccinimide ester (AC211) | 100 mg, 1 g | inquiry |
ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
ASSD-209 | Tetramethylrhodamine isothiocyanate Isomer R (AC209) | 5 mg, 10 mg | inquiry |
ASSD-144 | Oxazole Yellow Iodide (AC144) | 1 mg | inquiry |
ASSD-217 | t-Boc-MTSEA-Fluorescein (AC217) | 10 mg | inquiry |
ASSD-140 | A2B covalent ligand (AC140) | 50 μg | inquiry |
ASSD-205 | Acridinium C2 NHS Ester (AC205) | 5 mg, 10 mg | inquiry |
ASSD-151 | Acid Fuchsin (AC151) | 25 g | inquiry |
ASSD-103 | DAPI Staining Solution (1mg/mL) (AC103) | 1 mL, 5 mL, | inquiry |
We are committed to accelerating progress in stroke research and drug development.